Leqvio Launch Will Be Fundamental To Success Of New Novartis
Outcomes Data Key In EU, Not in US
Discussion of the launch trajectory for the twice-yearly cholesterol therapy dominated the marketing portion of Novartis’s investor event and the firm is confident the foundations have been laid to push strong sales growth by the second half of next year.
